33 related articles for article (PubMed ID: 38679709)
1. Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML.
Ohwada C; Nakaseko C; Ozawa S; Takeuchi M; Shono K; Koizumi M; Sakaida E; Cho R; Saito Y; Nishimura M
Bone Marrow Transplant; 2004 Dec; 34(11):999-1000. PubMed ID: 15448661
[No Abstract] [Full Text] [Related]
2. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
[TBL] [Abstract][Full Text] [Related]
3. How important is NK alloreactivity and KIR in allogeneic transplantation?
Shaffer BC; Hsu KC
Best Pract Res Clin Haematol; 2016 Dec; 29(4):351-358. PubMed ID: 27890259
[TBL] [Abstract][Full Text] [Related]
4. A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Ishida H; Kawahara Y; Tomizawa D; Okamoto Y; Hama A; Cho Y; Koh K; Koga Y; Yoshida N; Sato M; Terui K; Miyagawa N; Watanabe A; Takita J; Kobayashi R; Yamamoto M; Watanabe K; Okada K; Kato K; Matsumoto K; Hino M; Tabuchi K; Sakaguchi H
J Hematol Oncol; 2024 Apr; 17(1):24. PubMed ID: 38679709
[TBL] [Abstract][Full Text] [Related]
5. Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation.
Kawahara Y; Ishimaru S; Tanaka J; Kako S; Hirayama M; Kanaya M; Ishida H; Sato M; Kobayashi R; Kato M; Goi K; Saito S; Koga Y; Hashii Y; Kato K; Sato A; Atsuta Y; Sakaguchi H
Transplant Cell Ther; 2022 Sep; 28(9):598.e1-598.e8. PubMed ID: 35660064
[TBL] [Abstract][Full Text] [Related]
6. Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort.
Glushkova S; Shelikhova L; Voronin K; Pershin D; Vedmedskaya V; Muzalevskii Y; Kazachenok A; Kurnikova E; Radygina S; Ilushina M; Khismatullina R; Maschan A; Maschan M
Transplant Cell Ther; 2024 Apr; 30(4):435.e1-435.e12. PubMed ID: 38278183
[TBL] [Abstract][Full Text] [Related]
7. Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch.
Yokoyama H; Kanaya M; Iemura T; Hirayama M; Yamasaki S; Kondo T; Uchida N; Takahashi S; Tanaka M; Onizuka M; Ozawa Y; Kozai Y; Eto T; Sugio Y; Hamamura A; Kawakita T; Aotsuka N; Takada S; Wake A; Kimura T; Ichinohe T; Atsuta Y; Yanada M; Morishima S
Bone Marrow Transplant; 2022 Jul; 57(7):1171-1179. PubMed ID: 35538140
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
[TBL] [Abstract][Full Text] [Related]
9. Negative Impact of Unidirectional Host-versus-Graft Killer Cell Immunoglobulin-like Receptor Ligand Mismatch on Transplantation Outcomes after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia.
Yahng SA; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Kim HJ
Biol Blood Marrow Transplant; 2016 Feb; 22(2):316-323. PubMed ID: 26415557
[TBL] [Abstract][Full Text] [Related]
10. Higher Dose of CD34
Zhao F; Shi Y; Chen X; Zhang R; Pang A; Zhai W; Yang D; He Y; Feng S; Zhang P; Jiang E; Han M
Transplant Cell Ther; 2022 Sep; 28(9):589.e1-589.e10. PubMed ID: 35714907
[TBL] [Abstract][Full Text] [Related]
11. Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.
Yokoyama H; Kanda J; Kawahara Y; Uchida N; Tanaka M; Takahashi S; Onizuka M; Noguchi Y; Ozawa Y; Katsuoka Y; Ota S; Ohta T; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Nakasone H; Morishima S
Bone Marrow Transplant; 2021 Jun; 56(6):1352-1363. PubMed ID: 33420393
[TBL] [Abstract][Full Text] [Related]
12. Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia.
Verneris MR; Miller JS; Hsu KC; Wang T; Sees JA; Paczesny S; Rangarajan H; Lee DA; Spellman SR; Lee SJ
Blood Adv; 2020 Apr; 4(7):1350-1356. PubMed ID: 32267930
[TBL] [Abstract][Full Text] [Related]
13. A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study.
Davies SM; Iannone R; Alonzo TA; Wang YC; Gerbing R; Soni S; Kolb EA; Meshinchi S; Orchard PJ; Burns LJ; Shenoy S; Leung W
Biol Blood Marrow Transplant; 2020 Apr; 26(4):712-717. PubMed ID: 31870931
[TBL] [Abstract][Full Text] [Related]
14. The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia.
Keating AK; Langenhorst J; Wagner JE; Page KM; Veys P; Wynn RF; Stefanski H; Elfeky R; Giller R; Mitchell R; Milano F; O'Brien TA; Dahlberg A; Delaney C; Kurtzberg J; Verneris MR; Boelens JJ
Blood Adv; 2019 Apr; 3(7):1118-1128. PubMed ID: 30952678
[TBL] [Abstract][Full Text] [Related]
15. Which is more important for the selection of cord blood units for haematopoietic cell transplantation: the number of CD34-positive cells or total nucleated cells?
Nakasone H; Tabuchi K; Uchida N; Ohno Y; Matsuhashi Y; Takahashi S; Onishi Y; Onizuka M; Kobayashi H; Fukuda T; Ichinohe T; Takanashi M; Kato K; Atsuta Y; Yabe H; Kanda Y
Br J Haematol; 2019 Apr; 185(1):166-169. PubMed ID: 29808925
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
